BioCentury
ARTICLE | Company News

OncoMethylome, Roche deal

September 6, 2010 7:00 AM UTC

OncoMethylome will use its Methylation-Specific PCR technology to provide testing services to detect methylation of the O-6-methylguanine DNA methyltransferase ( MGMT) gene promoter in a Phase III tr...